Latest Insider Transactions at Krystal Biotech, Inc. (KRYS)
This section provides a real-time view of insider transactions for Krystal Biotech, Inc. (KRYS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Krystal Biotech, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Krystal Biotech, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 05
2022
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-0.46%
|
$2,025,000
$81.35 P/Share
|
|
Aug 05
2022
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Indirect |
25,000
-0.46%
|
$2,025,000
$81.35 P/Share
|
|
Aug 05
2022
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Direct |
25,000
-0.48%
|
$2,025,000
$81.35 P/Share
|
|
Feb 26
2022
|
Krish S Krishnan President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,655
-0.26%
|
$288,610
$62.5 P/Share
|
|
Feb 26
2022
|
Suma Krishnan President, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
3,282
-0.19%
|
$203,484
$62.5 P/Share
|
|
Feb 26
2022
|
Kathryn Romano Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,472
-7.51%
|
$91,264
$62.5 P/Share
|
|
Dec 10
2021
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-66.67%
|
$7,000,000
$70.5 P/Share
|
|
Dec 10
2021
|
Daniel Janney Director |
SELL
Open market or private sale
|
Indirect |
100,000
-27.3%
|
$7,000,000
$70.5 P/Share
|
|
Dec 10
2021
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Indirect |
100,000
-66.67%
|
$7,000,000
$70.5 P/Share
|
|
Feb 26
2021
|
Krish S Krishnan President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
40,800
+2.07%
|
-
|
|
Feb 26
2021
|
Kathryn Romano Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,600
+50.0%
|
-
|
|
Feb 26
2021
|
Suma Krishnan President, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
28,400
+1.5%
|
-
|